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Plasma  fibronectin  (FN) ~ is probably the  major nonimmune  particulate opsonin  of 
blood (1,  2).  FN is also cross-linked to fibrin during the final stage of blood coagulation 
(3,  4).  It was  first  identified in  1948  and  was  previously referred to  as cold insoluble 
globulin  (5).  FN  is  a  glycoprotein  composed  of high  molecular  weight  polypeptide 
subunits which is present in human plasma in concentrations of 300-400/zg/ml (3, 6). In 
the  last several years,  an  immunologically similar protein with a  200-200,000  mol wt 
polypeptide subunit has been found in the postculture medium of fibroblasts; the same 
antigen has been identified by immunofluorescence microscopy in vertebrate basement 
membrane  and  loose  connective  tissue  (7-9).  This  antigen  is  also  known  as  surface 
fibroblast antigen  (7),  large,  external,  transformation-sensitive protein  (10),  and  cell- 
surface protein (11).  Cultured fibroblasts (12-15) and astroglial cells (16) have previously 
been identified as sites of syntheis of FN.  FN in fibroblast cultures is found both in a 
soluble form in conditioned medium and in insoluble forms in the extracellular connec- 
tive tissue matrix and on the cell surface. The insoluble forms may be spatially related to 
collagen for when fibroblast cultures are studied by immunofluorescence microscopy, the 
same filamentous extracellular structures are labeled by both FN and collagen antibodies 
(17).  Also,  FN  has  recently been  shown  to  bind  to  collagen  (18).  FN  is  probably the 
protein in serum-containing tissue culture medium which mediates initial cell attach- 
ment  and  spreading  on  the  surfaces  of culture  vessels  (19-21).  FN  synthesized  and 
deposited underneath  cells may mediate adhesion of cells to culture dishes and other, 
more biologically relevant surfaces (22).  Transformed cultured fibroblasts generally lack 
cell surface FN (10,  11, 14-16, reviewed in 23). When purified FN is added to transformed 
cells, the transformed cells assume a more normal morphology and state of adhesiveness 
(24,  25). 
We and others have previously shown that cultured human endothelial cells synthesize 
extracellular material which  is morphologically and  immunologically like amorphous 
basement and contains basement membrane collagen (26, 27). Cultured endothelial cells 
also appear to synthesize extracellular material morphologically similar to microfibrils 
and  elastic  fibers  (26).  Recent  immunofluorescence  microscopic studies  have  demon- 
strated FN in the endothelium  and subendothelium of vessels in developing chicks (6) 
and in human tissues (28, 29). 
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In this paper, we report that cultured human endothelial cells synthesize FN 
with a polypeptide subunit mol wt of 200,000. Cultured endothelial cells secrete 
FN into culture medium and incorporate FN into the extracellular matrix. We 
suggest that endothelial cells may be a major site of synthesis of FN. 
Materials and Methods 
Cell  Culture  Techniques  and  Culture  Media.  Human  endothelial  cells  were  derived  from 
umbilical cords and cultured by using methods and materials previously described (30). Endothe- 
lial  cells were cultured  in plastic T-25  or T~75 flasks  (Coming Glass Works,  Science Products 
Div.,  Corning,  N.  Y.).  The  flasks  were  pretreated  by  incubation overnight at  4°C  with  0.2% 
gelatin (Difco Laboratories,  Detroit,  Mich.) in water.  The gelatin was removed just before use. 
Coverslips  on  which  cells  were  cultured  for  immunofluorescence  microscopy  were  similarly 
treated  with gelatin.  The culture  medium for endothelial cells consisted of medium  199  (Flow 
Laboratories, Inc., Rockville, Md.} containing either 20% fetal calf serum (Reheis Chemical Co., 
Chicago,  Ill.)  or 20%  normal  rabbit serum  (Pel-Freez  Farms  Inc.,  Rogers,  Ark.).  The culture 
media also  contained penicillin  (i00  U/ml), streptomycin (i00  ~glmIL L-glutamine (2 mM) (all 
Flow Laboratories)  and Hepes buffer  (15  mM, pH 7.4,  Sigma Chemical Co.,  St. Louis,  Mo.). 
Immunofluorescence Microscopy.  2-7 days after  subculture,  cultured  cells  were prepared  and 
processed  for  immunofluorescence microscopy by previously  described  methods (30,  31).  The goat 
anti-rabbit  IgG which was purified  by affinity  chromatography and conjugated with fluorescein 
according to methods previously described (32)  was kindly provided by Dr. Carl G. Becker 
(Cornell University Medical College, New  York). The various rabbit  antibodies and normal 
rabbit  serum were used  at  dilutions  of  1:10  or  1:20  and 20 ~l  of  antiserum  were used  per  coverslip. 
Immunofluorescence microscopy and photomicrography were performed by methods previously 
described  (30). 
Antibodies and Antigens.  Plasma FN and goat and rabbit  antibodies  to human plasma FN 
(designed  anti-FN) were prepared as previously  described (3, 4).  The unabsorbed rabbit  anti-FN 
had no detectable  anti-factor  VIII procoagulant activity  or anti-von Willebrand factor  activity 
when assayed by methods previously  described (33,  34).  However, due to the possibility  of  small 
amounts of  contaminating  factor  VIII antigen in  the material used to  elicit  the anti-FN sera,  all 
the anti-FN sera used in this  study were absorbed with purified  plasma factor  VIII (35)  before 
use. Anti-FN sera were absorbed by reacting  4 vol of  anti-FN with 1 vol of  purified  factor  VIII 
(0.98  mg/ml) at  37°C for  i  h and  overnight at  4°C.  The anti-FN sera  were then  centrifuged  at  8,000 
g for 20 min at 4°C. When the absorbed anti-FN sera and a well characterized  anti-factor  VIII 
serum (35)  were reacted in immunodiffusion against a mixture containing FN and factor  VIII, 
lines  of  nonidentity  were seen and the anti-factor  VIII  also  detected  free  factor  VIII  antigen in  the 
anti-FN sera.  When anti-factor  VIII and absorbed anti-FN sera were tested  by immunofluores- 
cence microscopy with  confluent  cultured  endothelial  cells,  the antisera  gave  different  patterns  of 
fluorescence.  The rabbit  anti-FN stained mainly an extensive meshwork of  extracellular  fibrils 
while  the anti-factor  VIII  stained  only intracellular  granules. 
The antisera to human serum albumin was obtained from Behring Diagnostics,  American 
Hoechst Corp.,  Somerville,  N. J. The antisera  to ovalbumin was kindly provided by Dr. Gordon 
D. Ross,  Cornell University Medical College,  New York. The antisera  to anti-thrombin III and 
prothrombin  were provided by Dr. Robert  Rosenberg, Harvard Medical School,  Boston, Mass. All 
antisera  were absorbed  with aluminum hydroxide and heat-inactivated  before  use. 
Quantitative Absorption  Studies.  Rabbit anti-FN was diluted 1:4 with phosphate-buffered 
saline  I[PBS] 0.145  M  NaCl, 0,01  M  phosphate, pH 7.4)  and 0.2-ml  portions  pipetted  into  a series 
of  Eppendorff  centrifuge  tubes.  To these were added serial  twofold dilutions  (0.2  ml) of  purified 
human FN, the  highest  concentration  being  488 ~g/tube.  The tubes were incubated with  frequent 
shaking at  37°C for  2 h and then at  4°C for  72 h. The precipitate  harvested by centrifugation  was 
washed four  times  in PBS, dissolved  in 1  N NaOH, and protein  content  determined  by the Lowry 
et al. procedure (36).  Portions  of  each supernate were used to treat  cultured endothelial  cells  as 
described above to determine if  absorption of anti-FN serum at equivalence with purified  FN 
would inhibit  immunofluorescence staining.  These preparations were compared with cultured 
endothelial cells  treated  with unabsorbed anti-FN at the same final  dilution (1:20)  as the ERIC  A.  JAFFE  AND  DEANE  F.  MOSHER  1781 
supernate and with cells treated with pooled normal rabbit serum. Using the data obtained from 
the  quantitative  immunoprecipitation  study  (Fig.  2),  we  calculated  that  the  anti-FN  serum 
contained 2.46 mg/ml of specific anti-FN antibody. 
Radial Immunodiffusion.  Radial immunodiffusion was performed by the method of Mancini 
et al. (37) with goat anti-FN at a final dilution of 1:140.  Confluent endothelial cells were cultured 
for 3 days in T-75 flasks in 10 ml of culture media containing 20% fetal calf serum. The postculture 
media was removed, centrifuged to remove debris, lyophilized, reconstituted in 1/5 the original 
volume of PBS, dialyzed against PBS, and analyzed. Human plasma of known FN concentration 
served  as  a  secondary  standard.  The  primary  standard  was  purified  plasma  FN;  protein 
concentration of the primary standard was determined by absorbance at 280 nm (6). The minimal 
level of FN detectable by this technique in a  10-~l sample was 40 ng.  Thus, the minimal level 
detectable in the culture media was 8 ~g/flask (10 ml of culture media). The goat anti-FN sera 
used in this study did not detect FN in preculture media or in the fetal calf serum used in the 
culture medium. 
Immunodiffusion  analysis.  Immunodiffusion analysis was performed on glass slides contain- 
ing 1% agarose in 50 mM Tris-barbital buffer pH 8.2. Samples to be tested (10 ~zl) were placed in 
4-mm diameter wells and the plates incubated at room temperature for 48 h. The anti-FN was 
used at a  dilution of 1:2. The plates were washed extensively with Tris-buffered saline and then 
water, stained with Coomassie Brilliant Blue, and photographed. 
Radioactively Labeled FN Synthesized  by Endothelial Cells.  Radioactively labeled FN  syn- 
thesized by endothelial cells was prepared by culturing monolayers of human endothelial cells 
in T-75 flasks in medium 199 containing 20% normal rabbit serum until the cells were confluent. 
The medium was then removed and the cells washed three times with Dulbecco's PBS. The cells 
were incubated in leucine-free minimal essential medium (MEM) (Flow Laboratories) containing 
20% heat inactivated rabbit serum for 30 min at 37°C.  This medium was removed and replaced 
with 10 ml of fresh leucine-free MEM containing 20% heat inactivated rabbit serum, L-J4, 5-3H] 
leucine (20 ~Ci/mol, sp act 50 Ci/mmol, Amersham Corp., Arlington Heights, Ill.), and Trasylol 
(50 U/ml, FBA Pharmaceuticals,  Inc., New  York) and the cells incubated for 24 h  at 37°C.  The 
postculture medium was removed and the following inhibitors added to it to yield the listed final 
concentration:  0.4  mM  phenyl methyl  sulfonyl  fluoride  (Sigma  Chemical  Co.),  5  mM N-ethyl 
maleimide (Sigma Chemical Co.), 10 mM EDTA, and 1 ~M pepstatin (Protein Research Founda- 
tion, Osaka, Japan). The postculture medium was centrifuged at 40,000 g for 1 h at 4°C to sediment 
particulate debris.  The supernate was made up to 50% saturation with ammonium sulfate,  in- 
cubated at 4°C overnight, and centrifuged at 40,000 g  for 1 h  at 4°C.  The precipitate from 2 T-75 
flasks was redissolved in PBS (1/10 original volume) containing the four inhibitors listed above, 
dialyzed at  4°C  against two changes of 2  liters each of PBS,  and stored frozen at  -40°C.  This 
procedure yielded  approximately  2 ml of a  protein solution containing 18.6  mg/ml protein and 
4.54  x  107 dpm/ml (sp act 2.44  x  10  ~ dpm/mg). 
The  [3H]-labeled  endothelial  cell  monolayers  were  washed  four  times  with  medium  199 
containing 10 -4  M  leucine  and once with medium  199  containing 10-4  M  leucine and 0.4  mM 
phenyl methyl sulfonyl fluoride.  The cell monolayers were then extracted for 2 h  at 37°C  with 
medium 199 containing 1 M urea and 0.4 mM phenyl methyl sulfonyl fluoride (11, 38). The extract 
was  removed  and  N-ethyl  maleimide,  EDTA,  and  pepstatin  added  to  yield  the  same  final 
concentrations as used in processing the pestculture medium. The urea extract was centrifuged at 
40,000 g  for 15 min and then dialyzed against PBS at 4°C.  This procedure yielded approximately 
6.5 ml of a solution containing 1.75  x  106 dpm/ml. 
Immunodiffusion  Analysis.  Immunodiffusion analysis was performed on glass slides contain- 
by cultured endothelial cells was  isolated from fractions derived from pestculture medium and 
from urea extracts of cellular monolayers by a method using anti-FN. The method used a Protein 
A-Sepharose column and is a  modification of the method of Kessler (39).  To inhibit proteolytic 
enzymes, phenyl methyl sulfonyl fluoride (0.4 mM), EDTA (10 mM), N-ethyl maleimide (5 mM), 
and pepstatin (1 ~M) were added to all buffer and protein solutions used in these procedures. 
Protein  A-Sepharose  4B  (Protein  A  bound  to  Sepharose  4B,  Pharmacia  Fine  Chemicals, 
Piscataway,  N.  J.)  was  washed  twice with 0.15  M  NaC1,  0.02  M  Tris-HC1,  pH  7.4  (TBS-Tris- 
buffered  saline).  0.2  ml  of the  washed  beads,  0.2  ml  TBS,  and  0.15  ml  of the  anti-FN  were 
incubated with end-over-end rotation for 2 h at 20°C. To saturate the remaining Protein A binding 
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4°C, and the beads then washed six times with PBS. The washed beads were suspended in 0.75 ml 
of PBS, 0.25 ml of the [3H]-labeled ammonium sulfate precipitated postculture meidum or 0.9 ml 
of  the  dialyzed  cell  extract  was  added,  and  the  mixture  incubated  overnight  at  4°C.  The 
suspension was transferred to  a  0.6  x  15 cm  chromatographic column  (Glenco Scientific Inc., 
Houston, Tex.) and the excess fluid drained off.  The beads (0.2 ml packed volume) were washed 
sequentially with PBS (6 ml), 5 M KI (8 ml}, 1% Triton X-100 (Sigma) in PBS (8 ml), and PBS (5 
ml). The beads were then eluted with 1 M acetic acid and the eluate analyzed by sodium dodecyl 
sulfate (SDS)-polyacrylamide gel electrophoresis. The washes with 5 M  KI and 1% Triton X-100 
were added because in preliminary experiments FN was noted to stick nonspeciflcally to Protein 
A-Sepharose. Kessler (39) has shown that 5 M KI and the nonionic detergent NP-40 do not release 
appreciable amounts~of antigen-antibody complexes bound to Protein A. We found that washes 
with 5 M KI and 1% Triton X-100 in PBS release nonspeciflcally bound FN but did not release FN 
bound to  anti-FN.  Control experiments were  performed  with anti-ovalbumin and  anti-human 
serum albumin. 
Immunoisolation of [3H] Endothelial Cell FN by Double Antibody Immunoprecipitation.  Double 
antibody  immunoprecipitation  reactions  were  carried  out  on  [3H]leucine-labeled  ammonium 
sulfate  precipitated  endothelial  cell  postculture  medium  prepared  as  above  except  that  the 
endothelial cells were  labeled while in fetal calf serum.  The cells were thus cultured  to avoid 
adding large amounts of rabbit gamma globulins which would have interfered with the second 
immunoprecipitation step (goat anti-rabbit IgG precipitating the rabbit anti-FN). 38 ill of rabbit 
anti-FN was added to 0.5 ml [3H]-labeled ammonium sulfate precipitated postculture medium and 
the mixture incubated for 2 h  at  37°C  and overnight at 4°C.  Goat anti-rabbit IgG (0.2 ml) was 
added and the mixture further incubated for 2 h  at 37°C and for 2 days at 4°C.  The mixture was 
centrifuged at 6000 g  for 5 min at 4°C. The supernate was removed and saved for analysis and the 
precipitate washed six times by centrifugation with PBS containing 0.5% Triton X-100 (39).  The 
supernates and pellets were then analyzed by SDS-polyacrylamide gel electrophoresis.  Control 
experiments were performed with anti-ovalbumin and anti-human serum albumin. Preliminary 
quantitative  immunoprecipitation  experiments  were  performed  to  determine  the  equivalence 
point for the reaction between the goat anti-rabbit IgG and the various antibodies. 
SDS-Polyacrylamide  Gel Electrophoresis.  SDS-polyacrylamide  gel  electrophoresis was  per- 
formed in 3% acrylamide-0.5% agarose gels by the method of Weinstein et al.  (40).  Samples in 1 
M acetic acid were prepared for electrophoresis by heating in sample buffer for 1 h  at 37°C.  The 
samples were then dialyzed against running buffer containing 1% SDS,  0.4 mM phenyl methyl 
sulfonyl fluoride, 5 mM N-ethyl maleimide,  10 mM EDTA,  and 1 ttM pepstatin for 2 h  at 20°C. 
Samples to be reduced were treated with 3 t~l/100 t~l of a 1.4 M dithiothreitol solution by boiling for 
5 min. Immunoprecipitates and samples not in acetic acid were solubilized by boiling for 5 min in 
sample buffer.  Gels were sectioned into 2-ram thick slices and processed for liquid scintillation 
counting either as previously described (35) or by incubating the gel slices in 10 ml of 3% Protosol 
in Econofluor (New England Nuclear Corp., Boston, Mass.) for 16-24 h at 37°C (the two methods 
yielded the  same results).  The samples  were counted  in a  Searle  Mark  III liquid scintillation 
counter (Searle Analytic Inc., Arlington Heights, Ill.). Purified human plasma factor VIII (sub- 
unit mol wt 202,000)  used as a marker was prepared as previously described (35).  Purified plasma 
FN used as a  marker (subunit mol wt 200,000) was purified as previously described (3). 
The 3% polyacrylamide-0.5% agarose system was chosen because in this system when samples 
are run unreduced, factor VIII and plasma FN are completely separated from each other whereas 
with reduction they have the same mobility (40). 
Results 
Immunofluorescence Studies.  When coverslips of confluent cultures of hu- 
man endothelial  cells,  cultured  in normal rabbit  serum and fixed  in acetone, 
were  sequentially  incubated  with  rabbit  anti-FN  and  fluorescein-conjugated 
goat  anti-rabbit  IgG,  meshworks  of extracellular  fibrils  covering all  the cells 
were  brightly  stained  (Fig.  1).  When  subconfluent  endothelial  cells  were 
similarly stained, few immunofluorescent extracellular fibrils were seen though 
large  numbers of brightly  fluorescent  intracellular  granules were present.  As ERIC  A.  JAFFE  AND  DEANE  F.  MOSHER  1783 
FIo.  1.  Immunofluorescence study of cultured human endothelial cells cultured in rabbit 
serum.  Cells were treated with rabbit anti-FN and then with fluorescein-conjugated goat 
anti-rabbit IgG. A  meshwork of extracellular fibrils is brightly stained; the cells are very 
lightly stained and are barely visible because the extracellular matrix stains so brightly 
(x 960). 
the cells became more confluent,  the numbers of intracellular  immunofluores- 
cent granules decreased somewhat and the extent of the extracellular immuno- 
fluorescent fibrillar meshwork greatly increased. The fibrils were not related to 
areas of cell-cell junctions,  instead they appeared to form a  continuous mesh- 
work underlying the cells. No staining was seen when the cultured endothelial 
cells were stained with normal rabbit serum,  anti-prothrombin,  or antisera to 
anti-thrombin III instead of anti-FN.  To demonstrate the endothelial origin and 
homogeneity of the cells,  parallel  coverslips were also stained  for factor VIII 
antigen  using an antibody to human  factor VIII antigen  (31,  35).  All the cells 
were brightly stained thus confirming their endothelial origin (31). 
Immunofluorescence staining of endothelial cells was completely inhibited by 
prior  absorption  at  equivalence  of anti-FN  serum  by  purified  FN  (Fig.  2). 
Supernates  from the zone of antigen  excess did not stain cultured endothelial 
cells, whereas supernates in the zone of antibody excess did. 
Endothelial  Cell FN.  For  this  study,  endothelial  cells  were  cultured  in 
media containing  20%  fetal calf serum  since the goat  anti-FN  was unable  to 
detect FN in fetal calf serum by immunodiffusion analysis. Pre- and postculture 
media were concentrated five-fold and assayed for FN by radial  immunodiffu- 
sion using goat anti-FN. Concentrated preculture media contained no detectable 
FN  (Table  I).  However,  concentrated  postculture  media  from  four  different 
endothelial cell strains did contain significant amounts of FN. 
Immunodiffusion  Studies.  On immunodiffusion  analysis,  goat anti-FN  re- 
acted with a  line  of identity when  tested against  endothelial  cell postculture 1784  FIBRONECTIN SYNTHESIS  BY  CULTURED  HUMAN  ENDOTHELIAL  CELLS 
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FIG. 2.  Quantitative precipitin  analysis of the FN-anti-FN reaction.  Serial dilutions  of 
purified  human FN (-©-) were added to  a constant amount of  rabbit  antiserum to  FN. The 
resulting  immunoprecipitates (-0-) were quantitated by the Lowry procedure. The ability 
of  the supernates to stain  cultured endothelial  cells  was tested  by immunofluorescence as 
detailed  in  the Materials and Methods section. 
TABLE  I 
FN Content of Pre and Postculture  Media 
Material tested*  FN$ 
pg/culture flask 
Preculture media  <8 
Postculture media 
Culture 
1  50 
2  25 
3  55 
4  77 
* Four different endothelial cell lines were cultured for 3 days and the 
media were concentrated  fivefold and analyzed by radial immunodif- 
fusion. 
$ The minimal amount  of FN detectable by this technique  was 8 /~g/ 
culture flask.  The values represent averages of two sets of analyses 
on multiple dilutions of each sample. 
medium and human plasma (Fig. 3). Preculture medium, which contained fetal 
calf serum, did not form a  precipitin line when tested against the goat anti-FN 
serum. 
Immunoisolation  of Endothelial  Cell  FN.  FN  synthesized by  endothelial 
cells was isolated from fractions of postculture media derived from endothelial 
cells cultured in 20% normal rabbit or fetal calf serum with [3H]  leucine in the 
presence of Trasylol (50 U/ml). The [3H]  FN was isolated either by a  technique 
using  Protein  A-Sepharose or  by  double  antibody immunoprecipitation. The 
Protein A-Sepharose technique utilized a rabbit anti-FN sera and cells cultured 
and labeled in rabbit serum to avoid interspecies cross-reactivity. The isolated ERIC  A.  JAFFE  AND  DEANE  F.  MOSHER  1785 
Fro.  3.  Immunodiffusion analysis of FN synthesized by endothelial cells. The center well 
(A) contained goat anti-human FN. The numbered wells contained: 1) preculture medium; 
2) human plasma; and 3) postculture medium. The stained immunodiffusion plate shows a 
line of identity between the FN in human plasma and the FN present in endothelial cell 
postculture medium. No FN was detected in the preculture medium. 
[3H] FN was characterized by SDS-polyacrylamide gel electrophoresis with and 
without reduction by dithiothreitol. 
A  fraction obtained  from  [3H] leucine-labeled endothelial cell  postculture 
medium  by  precipitation  with  ammonium  sulfate  at  50%  saturation  was 
electrophoresed,  sliced,  and  counted  for  radioactivity  (Fig.  4A).  This  gel 
contained three major radioactive peaks,  one of which comigrated with the 
human plasma FN  used as  a  marker.  The radioactively labeled ammonium 
sulfate  precipitated  postculture  medium  was  subjected  to  immunoisolation 
using anti-FN coupled to Protein A-Sepharose. After this procedure, analysis of 
the depleted labeled postculture media by SDS-polyacrylamide electrophoresis 
revealed that the radioactive peak comigrating with the plasma FN marker 
(Fig.  4A)  had  almost  completely  disappeared  (data  not  shown).  SDS-gel 
electrophoresis (after reduction) of the  acetic acid  eluate from the  anti-FN 
Protein A-Sepharose column (Fig.  4 B),  revealed one radioactive band with a 
mol wt of 200,000 which comigrated with the plasma FN marker. When the 
acetic acid eluate was electrophoresed without reduction (Fig.  4 C), one radio- 
active band was seen and it comigrated with the unreduced plasma FN marker. 
Control studies performed with anti-human serum albumin and anti-ovalbumin 
instead of anti-FN did not isolate any labeled material (Figs.  4 B and 4 C).  In 
this gel system (3% acrylamide-0.5% agarose) after reduction, the plasma factor 
VIII marker comigrated with the plasma FN marker. However, when factor 
VIII was electrophoresed without reduction, it did not enter the gel while the 
plasma FN marker did. Thus, this system could be used to completely separate 
FN and factor VIII (40). 
Labeling patterns identical to those seen in Fig. 4 were seen when radioac- 
tively labeled  ammonium sulfate precipitated postculture medium was  sub- 
jected to double antibody immunoprecipitation with rabbit anti-FN and goat 
anti-rabbit  IgG.  Control  double  antibody  immunoprecipitation experiments 1786  FIBRONECTIN  SYNTHESIS  BY  CULTURED  HUMAN  ENDOTHELIAL  CELLS 
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FIo.  4.  Protein A-Sepharose isolation of FN  synthesized by cultured endothelial cells. 
Distribution of radioactivity in SDS-polyacrylamide gels of: (A) fraction derived from pH] 
leucine-labeled endothelial cell postculture medium by precipitation with 50% saturated 
ammonium sulfate (reduced with dithiothreitol); (B) fraction derived by acetic acid elution 
of an anti-FN Protein A-Sepharose column which has been reacted with the  pH] leucine 
labeled, ammonium sulfate precipitated endothelial cell postculture medium shown in (A) 
and  then  washed  as  detailed  in  the  Materials  and  Methods  Section  (-0-0-).  Control 
experiments  were  performed  by  using  anti-human  serum  albumin  and  anti-ovalbumin 
(-O-O-) instead of anti-FN (all reduced with dithiothreitol); (C) same as (B) except unre- 
duced by dithiothreitol. The arrows labeled FN represent the location of the plasma  FN 
marker run on companion gels.  When reduced,  plasma  FN  electrophoreses as  a  closely 
spaced doublet with an average mol wt of 200,000,  hence the double arrow. 
using  anti-human  serum  albumin  and  anti-ovalbumin  instead  of  anti-FN 
precipitated no labeled material. 
Since essentially all  (---95%) the radioactivity in the high  molecular weight 
peak  comigrating  with  plasma  FN marker  (Fig.  4A) was FN and  that  peak 
represented  -15% of the output of PH] leucine-labeled protein by the endothe- 
lial  cells,  we  estimate  that  FN  represents  -15%  of the  protein  released  by 
endothelial cells into the culture medium. 
Endothelial  cell monolayers labeled with  PH] leucine were extracted with 1 
M urea for 2 h at 37°C since it has been shown that insoluble fibroblast FN can 
be extracted using this procedure (11, 38). The urea extract was analyzed by the 
Protein A-Sepharose technique described above. Labeling patterns identical to 
those seen in Fig.  4 B  and  4 C were obtained.  Control  experiments  performed 
with anti-ovalbumin instead of anti-FN did not isolate any labeled material. ERIC  A.  JAFFE  AND  DEANE  F.  MOSHER  1787 
Discussion 
The studies reported here demonstrate that cultured human endothelial cells 
synthesize  and  release  FN  into  culture  media  and  incorporate  FN  into  the 
extracellular matrix.  The radioactive FN secreted by endothelial cells into the 
culture medium and incorporated into the extracellular matrix comigrated with 
the  plasma  FN marker  on  SDS-polyacrylamide gel electrophoresis both with 
and without reduction and had a  single polypeptide subunit of 200,000 tool wt 
similar  to  the  plasma  FN  marker.  On  immunodiffusion  analysis,  the  FN 
secreted by cultured endothelial cells into their postculture medium formed a 
line of identity with human  plasma when both were reacted against anti-FN. 
Thus, the FN synthesized and secreted by endothelial cells and plasma FN are 
immunologically identical and are both disulfide bonded dimers with subunits 
of the same molecular weight. 
The validity of our studies is dependent on the specificity of the anti-FN sera 
used. These antibodies have previously been shown to form a  single line when 
tested against human plasma by immunodiffusion analysis and immunoelectro- 
phoresis (3, 4). The quantitive immunoprecipitin curve and the loss of immuno- 
fluorescence at equivalence (Fig. 2) also argue strongly for monospecificity. We 
have previously shown that cultured endothelial cells contain,  synthesize, and 
release factor VIII antigen  (31,33, 35). To avoid the possibility of contamination 
of the  anti-FN  with trace  amounts  of anti-factor  VIII,  all  anti-FN  sera were 
absorbed with purified plasma factor VIII before use. These absorptions and the 
patterns of mobility of the [3H] FN peaks seen in Fig. 4 rule out the possibility 
that  the  isolated  radioactive  peaks  seen  in  Figs.  4 B  and  4 C  are  factor  VIII 
antigen. 
FN  is  one  of  the  major  proteins  synthesized  and  secreted  by  cultured 
endothelial  cells.  It appears to constitute  -15% of the protein released by the 
cells  into  the  culture  media.  By comparison,  factor VIII antigen  represented 
only 5.5% of a  high  molecular fraction  (separated by Sepharose 6B) prepared 
from the same starting material  (31) and thus probably represented <1% of the 
total protein released by the cells into the culture medium. These estimates are 
consistent with the concentrations of these proteins in plasma,  i.e.  factor VIII 
antigen  -5-10  ~g/ml  and  plasma  FN  -330  ~g/ml  (1).  Cultures  of human 
endothelial cells secreted (Table I) an average of 51.8 ~g FN/25 cm  '~ dish during 
3 days in culture.  By comparison,  a  variety of first passage human embryonic 
cell strains secreted an average of 106 ~tg FN/25 cm  2 dish (equivalent) during 3 
days in culture (15, 41). Thus, endothelial cells synthesize and release into their 
culture  medium  significant  amounts  of  FN  having  subunits  of  the  same 
molecular weight as those found in human plasma. 
FN has been shown to be present in the endothelium and subendothelium of 
a  variety of blood vessels.  Linder et al.  (7) in studies on the developing chick 
embryo showed that  in  addition  to  primitive  mesenchymal  tissue  and  basal 
lamina,  endothelial cells and the subendotheium of arteries and veins and also 
of brain capillaries contained  FN when tissue sections were studied by immu- 
nofluorescence microscopy. FN was absent in parenchymal cells in a  variety of 
organs  such  as  the  liver,  striated  and  smooth  muscle,  brain  (except neural 
sheaths),  cartilage,  and bone. Similar immunofluorescence studies on a variety 1788  FIBRONECTIN SYNTHESIS BY  CULTURED HUMAN ENDOTHELIAL CELLS 
of human tissues have shown that FN is most prominently seen associated with 
endothelial  cells  (28,  29).  In  addition,  FN was also seen in basal lamina,  the 
media  of blood vessels,  and  loose connective tissue  (29).  Our  present  data  in 
conjunction with these immunofluorescence studies and the location of endothe- 
lial  cells  (adjacent  to  the  blood stream)  suggest  that  endothelial  cells  are  a 
major site of synthesis of plasma FN. 
A physiologic role of FN in plasma has just been demonstrated. FN has shown 
to be identical to human  a2 opsonic glycoprotein which is thought to have the 
important restorative function of mediating the uptake of colloids and intravas- 
cular particulates by the reticuloendothelial  system (1, 2,  42,  43).  Our in vitro 
study  and  the  immunofluorescence  studies  performed  on  tissue  sections  by 
others (7, 28,  29) have shown that the extracellular  matrix of endothelial cells 
contains  FN.  The physiologic role of FN in tissues has been inferred from its 
effects on cultured cells.  FN is necessary for the attachment  of tissue culture 
cells to culture vessels (19-22). FN also increases the strength of attachment of 
transformed cells to culture vessels and thus changes their morphology (though 
not their growth characteristics  and malignant  potential)  (24,  25).  The mecha- 
nism of these two effects is unknown.  Fibroblast cultures contain fibrils which 
stain for both FN and collagen when examined by immunofluorescence micros- 
copy (17). The basis for this congruence of location may be the recently described 
noncovalent interactions of FN with other FN molecules (44) and with collagen 
(18). FN crosslinks with itself and other proteins through disulfide links (9, 45). 
FN on cell surfaces is known to be immobile and may serve as an anchorage 
point  for  cell  attachment  (44).  Thus,  FN  in  the  subendothelium  may  be an 
important  structural  component which plays a  role in endothelial  cell attach- 
ment and adhesiveness under normal conditions and after injury to the vascular 
wall. 
Summary 
Plasma fibronectin is probably the major nonimmune particulate opsonin in 
blood and is cross-linked to fibrin during the final stage of blood coagulation. 
Fibronectin also occurs in an insoluble form in basement membranes especially 
those underlying endothelial cells and in loose connective tissue. 
Fibronectin was demonstrated in cultured human endothelial cells and in the 
surrounding extracellular  matrix by immunofluorescence microscopy by using 
antibody  to  human  plasma  fibronectin.  Cultured  human  endothelial  cells 
released  fibronectin  into  the  culture  medium  which  was  immunologically 
identical to the fibronectin in human plasma.  Cultured human endothelial cells 
were  labeled  with  [3H] leucine.  The  radioactive  fibronectin  present  in  the 
endothelial postculture medium and in urea extracts of cellular monolayers was 
isolated with either  anti-fibronectin  coupled to Protein A-Sepharose or double 
antibody  immunoprecipitation  and  characterized  by sodium  dodecyl sulfate- 
polyacrylamide gel electrophoresis. When reduced, the [3H] fibronectin synthe- 
sized by cultured endothelial cells had the same mol wt (-200,000)  as plasma 
fibronectin.  Unreduced,  the  [3H] fibronectin  synthesized  by endothelial  cells 
migrated as a dimer, as did plasma fibronectin. Fibronectin accounted for -15% 
of the  protein  synthesized  and  released  by endothelial  cells  into  the  culture 
medium. ERIC  A.  JAFFE  AND  DEANE  F.  MOSHER  1789 
Thus,  cultured  endothelial  cells  synthesize  fibronectin,  secrete  it  into  the 
culture  medium,  and  incorporate  it  into  extracellular  matrix.  The  results 
suggest  that  the  endothelial  cell  is  potentially  a  major  site  of synthesis  of 
circulating plasma fibronectin. In addition, fibronectin derived from endothelial 
cells may be an important structural component of the subendothelium. 
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